By on

Supermodel Helena Christensen has teamed up with fashion giant Tommy Hilfiger to design a new bag to benefit charity.

Christensen – who was named as an ambassador for Tommy Hilfiger’s limited edition bag initiative earlier this year – has designed a yellow oversized tote in super soft leather with a metal knot detail clasp. Perfect for pleasure and leisure, the limited edition bag costs £279, with 50% of the profits going to Breast Health International.

“I am honored to be chosen as ambassador of such a worthy cause and initiative. Breast cancer affects women of all ages worldwide, and I commend the Breast Health International and Tommy Hilfiger for stepping up to the mark, to find a cure for this disease,” said Christensen, who has been a supporter of the Fashion Targets Breast Cancer campaign for several years.

Proceeds from the bags will go to Breast Health International’s Fund For Living, an initiative established to provide assistance to all people with breast cancer and their families to cover unique problems that may not be addressed or covered by the usual health insurance programs, such as home care, child care, transportation. Resources to cover the costs of these special needs are made available to medical centers and social service facilities to be dispensed as needed to the patients and families in their individual treatment facilities.

“This Limited Edition bag symbolizes our commitment to the foundation, and with Helena Christensen, we hope to raise awareness and reduce the effects of breast cancer,” said Tommy Hilfiger.

The bag is only available in Tommy Hilfiger flagship stores.

comments powered by Disqus

Latest news

Cool Comedy • Hot Cuisine Raises Over $1.3 Million for Scleroderma Research Foundation

Cool Comedy • Hot Cuisine Raises Over $1.3 Million for Scleroderma Research Foundation Nov 5, 2024

Last week, in a special evening honoring John Mayer and Jeff Ross, Cool Comedy • Hot Cuisine raised more than $1.3 million for the Scleroderma Research Foundation (SRF)—the country’s first and leading nonprofit investor in medical research into scleroderma. More
More news